Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
266M
-
Number of holders
-
117
-
Total shares
-
48.6M
-
Shares change
-
-1.44M
-
Total reported value, excl. options
-
$187M
-
Value change
-
-$3.41M
-
Put/Call ratio
-
1.4
-
Number of buys
-
61
-
Number of sells
-
-59
-
Price
-
$3.85
Significant Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) as of Q2 2024
filings reported holding OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") as of Q2 2024.
Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.6M shares
of 266M outstanding shares and own 18.27% of the company stock.
Largest 10 shareholders include FMR LLC (7.7M shares), AMERIPRISE FINANCIAL INC (5.2M shares), MORGAN STANLEY (3.82M shares), JPMORGAN CHASE & CO (3.07M shares), VANGUARD GROUP INC (2.65M shares), MILLENNIUM MANAGEMENT LLC (1.94M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.54M shares), Assenagon Asset Management S.A. (1.52M shares), GMT CAPITAL CORP (1.47M shares), and Mubadala Investment Co PJSC (1.44M shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.